These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 23046138)

  • 1. Structural and dynamic determinants of type I interferon receptor assembly and their functional interpretation.
    Piehler J; Thomas C; Garcia KC; Schreiber G
    Immunol Rev; 2012 Nov; 250(1):317-34. PubMed ID: 23046138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NMR backbone dynamics of the human type I interferon binding subunit, a representative cytokine receptor.
    Chill JH; Quadt SR; Anglister J
    Biochemistry; 2004 Aug; 43(31):10127-37. PubMed ID: 15287740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The EM structure of a type I interferon-receptor complex reveals a novel mechanism for cytokine signaling.
    Li Z; Strunk JJ; Lamken P; Piehler J; Walz T
    J Mol Biol; 2008 Mar; 377(3):715-24. PubMed ID: 18252254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor dimerization dynamics as a regulatory valve for plasticity of type I interferon signaling.
    Wilmes S; Beutel O; Li Z; Francois-Newton V; Richter CP; Janning D; Kroll C; Hanhart P; Hötte K; You C; Uzé G; Pellegrini S; Piehler J
    J Cell Biol; 2015 May; 209(4):579-93. PubMed ID: 26008745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon Receptor Trafficking and Signaling: Journey to the Cross Roads.
    Zanin N; Viaris de Lesegno C; Lamaze C; Blouin CM
    Front Immunol; 2020; 11():615603. PubMed ID: 33552080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The molecular basis for functional plasticity in type I interferon signaling.
    Schreiber G; Piehler J
    Trends Immunol; 2015 Mar; 36(3):139-49. PubMed ID: 25687684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential receptor subunit affinities of type I interferons govern differential signal activation.
    Jaks E; Gavutis M; Uzé G; Martal J; Piehler J
    J Mol Biol; 2007 Feb; 366(2):525-39. PubMed ID: 17174979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multifaceted activities of type I interferon are revealed by a receptor antagonist.
    Levin D; Schneider WM; Hoffmann HH; Yarden G; Busetto AG; Manor O; Sharma N; Rice CM; Schreiber G
    Sci Signal; 2014 May; 7(327):ra50. PubMed ID: 24866020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural linkage between ligand discrimination and receptor activation by type I interferons.
    Thomas C; Moraga I; Levin D; Krutzik PO; Podoplelova Y; Trejo A; Lee C; Yarden G; Vleck SE; Glenn JS; Nolan GP; Piehler J; Schreiber G; Garcia KC
    Cell; 2011 Aug; 146(4):621-32. PubMed ID: 21854986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of Ligand Specificity and Functional Plasticity in Type I Interferon Signaling.
    Kirby D; Parmar B; Fathi S; Marwah S; Nayak CR; Cherepanov V; MacParland S; Feld JJ; Altan-Bonnet G; Zilman A
    Front Immunol; 2021; 12():748423. PubMed ID: 34691060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational and structural analysis of the binding interface between type I interferons and their receptor Ifnar2.
    Piehler J; Schreiber G
    J Mol Biol; 1999 Nov; 294(1):223-37. PubMed ID: 10556041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of the human type I interferon receptor binding site on human interferon-alpha2 by cross saturation and an NMR-based model of the complex.
    Quadt-Akabayov SR; Chill JH; Levy R; Kessler N; Anglister J
    Protein Sci; 2006 Nov; 15(11):2656-68. PubMed ID: 17001036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human interferon-ϵ and interferon-κ exhibit low potency and low affinity for cell-surface IFNAR and the poxvirus antagonist B18R.
    Harris BD; Schreiter J; Chevrier M; Jordan JL; Walter MR
    J Biol Chem; 2018 Oct; 293(41):16057-16068. PubMed ID: 30171073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral responses in mouse embryonic stem cells: differential development of cellular mechanisms in type I interferon production and response.
    Wang R; Wang J; Acharya D; Paul AM; Bai F; Huang F; Guo YL
    J Biol Chem; 2014 Sep; 289(36):25186-98. PubMed ID: 24966329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization of a receptor nonapeptide with a possible role in the binding of the type I interferons.
    Eid P; Langer JA; Bailly G; Lejealle R; Guymarho J; Tovey MG
    Eur Cytokine Netw; 2000 Dec; 11(4):560-73. PubMed ID: 11125298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential recognition of the type I interferon receptor by interferons tau and alpha is responsible for their disparate cytotoxicities.
    Subramaniam PS; Khan SA; Pontzer CH; Johnson HM
    Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12270-4. PubMed ID: 8618883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical role of the endogenous interferon ligand-receptors in type I and type II interferons response.
    Lasfar A; Cook JR; Cohen Solal KA; Reuhl K; Kotenko SV; Langer JA; Laskin DL
    Immunology; 2014 Jul; 142(3):442-52. PubMed ID: 24597649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STAT2 is an essential adaptor in USP18-mediated suppression of type I interferon signaling.
    Arimoto KI; Löchte S; Stoner SA; Burkart C; Zhang Y; Miyauchi S; Wilmes S; Fan JB; Heinisch JJ; Li Z; Yan M; Pellegrini S; Colland F; Piehler J; Zhang DE
    Nat Struct Mol Biol; 2017 Mar; 24(3):279-289. PubMed ID: 28165510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of interferon reduces the force of unfolding for interferon receptor 1.
    Chuartzman SG; Nevo R; Waichman S; Shental D; Piehler J; Levy Y; Reich Z; Kapon R
    PLoS One; 2017; 12(4):e0175413. PubMed ID: 28403186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of residues of the IFNAR1 chain of the type I human interferon receptor critical for ligand binding and biological activity.
    Cajean-Feroldi C; Nosal F; Nardeux PC; Gallet X; Guymarho J; Baychelier F; Sempé P; Tovey MG; Escary JL; Eid P
    Biochemistry; 2004 Oct; 43(39):12498-512. PubMed ID: 15449939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.